Skip main navigation

Implications of Mitral Annular Calcification on Outcomes Following Mitral Transcatheter Edge-to-Edge Repair

Originally published Cardiovascular Interventions. 2024;17


    Limited data exist regarding the impact of mitral annular calcification (MAC) on outcomes of transcatheter edge-to-edge repair for mitral regurgitation (MR).


    We retrospectively analyzed 968 individuals (median age, 79 [interquartile range, 70–86] years; 60.0% males; 51.8% with functional MR) who underwent an isolated, first-time intervention. Stratified by MAC extent per baseline transthoracic echocardiogram, the cohort was assessed for residual MR, functional status, all-cause mortality, heart failure hospitalizations, and mitral reinterventions post-procedure.


    Patients with above-mild MAC (n=101; 10.4%) were older and more likely to be female, exhibited a greater burden of comorbidities, and presented more often with severe, primary MR. Procedural aspects and technical success rate were unaffected by MAC magnitude, as was the significant improvement from baseline in MR severity and functional status along the first postprocedural year. However, the persistence of above-moderate MR or functional classes III and IV at 1 year and the cumulative incidence of reinterventions at 2 years were overall more pronounced within the above-mild MAC group (significant MR or functional impairment, 44.7% versus 29.9%, P=0.060; reinterventions, 11.9% versus 6.2%, P=0.033; log-rank P=0.035). No link was demonstrated between MAC degree and the cumulative incidence or risk of mortality and mortality or heart failure hospitalizations. Differences in outcomes frequencies were mostly confined to the primary MR subgroup, in which patients with above-mild MAC also experienced earlier, more frequent 2-year heart failure hospitalizations (20.8% versus 9.6%; P=0.016; log-rank P=0.020).


    Mitral transcatheter edge-to-edge repair in patients with and without above-mild MAC is equally feasible and safe; however, its postprocedural course is less favorable among those with primary MR.


    For Sources of Funding and Disclosures, see page 151.

    Supplemental Material is available at

    Correspondence to: Robert J. Siegel, MD, Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, 127 S San Vicente Blvd, A3100, Los Angeles, CA 90048. Email


    • 1. Fusini L, Ghulam Ali S, Tamborini G, Muratori M, Gripari P, Maffessanti F, Celeste F, Guglielmo M, Cefalù C, Alamanni F, et al. Prevalence of calcification of the mitral valve annulus in patients undergoing surgical repair of mitral valve prolapse.Am J Cardiol. 2014; 113:1867–1873. doi: 10.1016/j.amjcard.2014.03.013CrossrefMedlineGoogle Scholar
    • 2. Kanjanauthai S, Nasir K, Katz R, Rivera JJ, Takasu J, Blumenthal RS, Eng J, Budoff MJ. Relationships of mitral annular calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA).Atherosclerosis. 2010; 213:558–562. doi: 10.1016/j.atherosclerosis.2010.08.072CrossrefMedlineGoogle Scholar
    • 3. Fox CS, Larson MG, Vasan RS, Guo CY, Parise H, Levy D, Leip EP, O’donnell CJ, D’Agostino RBS, Benjamin EJ. Cross-sectional association of kidney function with valvular and annular calcification: the Framingham Heart Study.J Am Soc Nephrol. 2006; 17:521–527. doi: 10.1681/ASN.2005060627CrossrefMedlineGoogle Scholar
    • 4. Labovitz AJ, Nelson JG, Windhorst DM, Kennedy HL, Williams GA. Frequency of mitral valve dysfunction from mitral anular calcium as detected by Doppler echocardiography.Am J Cardiol. 1985; 55:133–137. doi: 10.1016/0002-9149(85)90314-5CrossrefMedlineGoogle Scholar
    • 5. O’Neal WT, Efird JT, Nazarian S, Alonso A, Heckbert SR, Soliman EZ. Mitral annular calcification and incident atrial fibrillation in the multi-ethnic study of atherosclerosis.Europace. 2015; 17:358–363. doi: 10.1093/europace/euu265CrossrefMedlineGoogle Scholar
    • 6. Rasmussen JH, Fredgart MH, Lindholt JS, Johansen JB, Sandgaard N, Yousef AH, Hasific S, Sønderskov P, Steffensen FH, Frost L, et al. Mitral annulus calcification and cardiac conduction disturbances: a DANCAVAS sub-study.J Cardiovasc Imaging. 2022; 30:62–75. doi: 10.4250/jcvi.2021.0110CrossrefMedlineGoogle Scholar
    • 7. Ribeiro RVP, Yanagawa B, Légaré JF, Hassan A, Ouzounian M, Verma S, Friedrich JO. Clinical outcomes of mitral valve intervention in patients with mitral annular calcification: a systematic review and meta-analysis.J Card Surg. 2020; 35:66–74. doi: 10.1111/jocs.14325CrossrefMedlineGoogle Scholar
    • 8. Obadia JF, Messika-Zeitoun D, Leurent G, Iung B, Bonnet G, Piriou N, Lefèvre T, Piot C, Rouleau F, Carrié D, et al; MITRA-FR Investigators. Percutaneous repair or medical treatment for secondary mitral regurgitation.N Engl J Med. 2018; 379:2297–2306. doi: 10.1056/NEJMoa1805374CrossrefMedlineGoogle Scholar
    • 9. Stone GW, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant B, Grayburn PA, Rinaldi M, Kapadia SR, et al; COAPT Investigators. Transcatheter mitral-valve repair in patients with heart failure.N Engl J Med. 2018; 379:2307–2318. doi: 10.1056/NEJMoa1806640CrossrefMedlineGoogle Scholar
    • 10. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, et al; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation.N Engl J Med. 2011; 364:1395–1406. doi: 10.1056/NEJMoa1009355CrossrefMedlineGoogle Scholar
    • 11. Cheng R, Tat E, Siegel RJ, Arsanjani R, Hussaini A, Makar M, Mizutani Y, Trento A, Kar S. Mitral annular calcification is not associated with decreased procedural success, durability of repair, or left ventricular remodelling in percutaneous edge-to-edge repair of mitral regurgitation.EuroIntervention. 2016; 12:1176–1184. doi: 10.4244/EIJV12I9A191CrossrefMedlineGoogle Scholar
    • 12. Fernández-Peregrina E, Pascual I, Freixa X, Tirado-Conte G, Estévez-Loureiro R, Carrasco-Chinchilla F, Benito-González T, Asmarats L, Sanchís L, Jiménez-Quevedo P, et al. Transcatheter edge-to-edge mitral valve repair in patients with mitral annulus calcification.EuroIntervention. 2022; 17:1300–1309. doi: 10.4244/EIJ-D-21-00205CrossrefMedlineGoogle Scholar
    • 13. Stone GW, Adams DH, Abraham WT, Kappetein AP, Généreux P, Vranckx P, Mehran R, Kuck KH, Leon MB, Piazza N, et al; Mitral Valve Academic Research Consortium (MVARC). Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the mitral valve academic research consortium.J Am Coll Cardiol. 2015; 66:308–321. doi: 10.1016/j.jacc.2015.05.049CrossrefMedlineGoogle Scholar
    • 14. Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance.J Am Soc Echocardiogr. 2017; 30:303–371. doi: 10.1016/j.echo.2017.01.007CrossrefMedlineGoogle Scholar
    • 15. Zamorano JL, Badano LP, Bruce C, Chan KL, Gonçalves A, Hahn RT, Keane MG, La Canna G, Monaghan MJ, Nihoyannopoulos P, et al. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease.J Am Soc Echocardiogr. 2011; 24:937–965. doi: 10.1016/j.echo.2011.07.003CrossrefMedlineGoogle Scholar
    • 16. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.J Am Soc Echocardiogr. 2015; 28:1–39.e14. doi: 10.1016/j.echo.2014.10.003CrossrefMedlineGoogle Scholar
    • 17. Barasch E, Gottdiener JS, Larsen EK, Chaves PH, Newman AB, Manolio TA. Clinical significance of calcification of the fibrous skeleton of the heart and aortosclerosis in community dwelling elderly the Cardiovascular Health Study (CHS).Am Heart J. 2006; 151:39–47. doi: 10.1016/j.ahj.2005.03.052CrossrefMedlineGoogle Scholar
    • 18. Raposeiras-Roubin S, Adamo M, Freixa X, Arzamendi D, Benito-González T, Montefusco A, Pascual I, Nombela-Franco L, Rodes-Cabau J, Shuvy M, et al. A score to assess mortality after percutaneous mitral valve repair.J Am Coll Cardiol. 2022; 79:562–573. doi: 10.1016/j.jacc.2021.11.041CrossrefMedlineGoogle Scholar
    • 19. Chan V, Messika-Zeitoun D, Labinaz M, Barili F, La Canna G, Buzzatti N, Pappalardo F, Calabrese M, Nisi T, Alfieri O, et al. Mitral annular calcification is associated with recurrent mitral regurgitation after percutaneous mitral repair.Circulation. 2019; 140:A16452. doi: 10.1161/CIRCULATIONAHA.113.007885LinkGoogle Scholar
    • 20. Oguz D, Padang R, Rashedi N, Pislaru SV, Nkomo VT, Mankad SV, Malouf JF, Guerrero M, Reeder GS, Eleid MF, et al. Risk for increased mean diastolic gradient after transcatheter edge-to-edge mitral valve repair: a quantitative three-dimensional transesophageal echocardiographic analysis.J Am Soc Echocardiogr. 2021; 34:595–603.e2. doi: 10.1016/j.echo.2021.01.018CrossrefMedlineGoogle Scholar
    • 21. Baudo M, Petruccelli RD, Muneretto C. Mitral valve surgery with extensive annular calcification: review of surgical techniques and postoperative complications.J Cardiovasc Med (Hagerstown). 2022; 23:285–289. doi: 10.2459/JCM.0000000000001242CrossrefMedlineGoogle Scholar
    • 22. Kalbacher D, Schäfer U, Bardeleben RSV, Eggebrecht H, Sievert H, Nickenig G, Butter C, May AE, Bekeredjian R, Ouarrak T, et al. Long-term outcome, survival and predictors of mortality after mitraclip therapy: results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry.Int J Cardiol. 2019; 277:35–41.CrossrefMedlineGoogle Scholar
    • 23. Kaneko H, Neuss M, Weissenborn J, Butter C. Prognostic significance of right ventricular dysfunction in patients with functional mitral regurgitation undergoing MitraClip.Am J Cardiol. 2016; 118:1717–1722. doi: 10.1016/j.amjcard.2016.08.054CrossrefMedlineGoogle Scholar
    • 24. Kar S, von Bardeleben RS, Rottbauer W, Mahoney P, Price MJ, Grasso C, Williams M, Lurz P, Ahmed M, Hausleiter J, et al. Contemporary outcomes following transcatheter edge-to-edge repair: 1-year results from the EXPAND study.J Am Coll Cardiol Interv. 2023; 16:589–602. doi: 10.1016/j.jcin.2023.01.010CrossrefGoogle Scholar
    • 25. Giordano A, Ferraro P, Finizio F, Biondi-Zoccai G, Denti P, Bedogni F, Rubbio AP, Petronio AS, Bartorelli AL, Mongiardo A, et al. Implantation of one, two or multiple MitraClip™ for transcatheter mitral valve repair: insights from a 1824-patient multicenter study.Panminerva Med. 2022; 64:1–8. doi: 10.23736/S0031-0808.21.04497-9CrossrefMedlineGoogle Scholar